Pharmacological inhibition of uterine activity.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D006801:Humans; D007473:Ion Channels; D008278:Magnesium Sulfate / Q000494:pharmacology; D009215:Myometrium / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D014590:Uterine Contraction / Q000187:drug effects*; D014599:Uterus / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D002121:Calcium Channel Blockers; D016861:Cyclooxygenase Inhibitors; D007473:Ion Channels; D000431:Ethanol; D011374:Progesterone; D008278:Magnesium Sulfate; D002118:Calcium